Le vaccin chinois de Sinovac Biotech Ltd. Jugé efficace par l’Indonésie

Selon l’agence Bloomberg, l’Indonésie s’est réjouie de l’efficacité du vaccin chinois Sinovac avec lequel elle a traité les agents de santé de la capitale Jakarta. (lire la suite)

Selon le ministre indonésien de la santé, le suivi de plus de 25 000 agents vaccinés contre la Covid avec Sinovac a permis de constater que durant les 28 jours après la vaccination, aucun d’entre eux n’était décédé et que dès le 7ème jour, 97% de ceux-ci avaient éviter l’hospitalisation. Les données, poursuit l’agence, s’ajoutent aux signes positifs en provenance du Brésil selon lesquels le vaccin Sinovac est plus efficace qu’il ne l’a prouvé lors de la phase de test.

L’Indonésie a été l’un des premiers pays à parier sur un vaccin chinois. En janvier, le président Joko Widodo est devenu le premier grand dirigeant mondial à recevoir une injection de Sinovac dans le but d’apaiser le scepticisme au pays et à l’étranger. Depuis lors, la plus grande économie d’Asie du Sud-Est a administré plus de 22 millions de doses, principalement du Sinovac, alors qu’elle cherche à atteindre l’immunité collective pour ses 270 millions d’habitants d’ici la fin de l’année.

Le Cambodge a reçu en don ou acheté plus de 2 millions de doses de Sinovac. 60% de la population soit 10 millions de personnes devraient être vaccinées à la mi 2022 selon l’agenda du gouvernement.

According to Bloomberg, Indonesia was delighted with the effectiveness of the Chinese Sinovac vaccine with which it treated health workers in the capital Jakarta. According to the Indonesian Ministry of Health, more than 25,000 of the workers vaccinated with Sinovac showed promising signs within 28 days after vaccination. None of them had died and that from the 7 ^th day following vaccination, 97% of these had avoided hospitalization. The data, the agency continues, adds to positive signs from Brazil that the Sinovac vaccine is more effective than it has been proven during the testing phase.

Indonesia was one of the first countries to show confidence in the Chinese vaccine. In January, President Joko Widodo became the first great world leader to receive an injection of Sinovac in an attempt to quell skepticism at home and abroad. Since then, Southeast Asia’s largest economy has administered more than 22 million doses, mostly of Sinovac, as it seeks to achieve collective immunity for its 270 million people by the end of the year.

Cambodia has donated and/or purchased over 2 million total doses of Sinovac. According to the government’s agenda, 60% of the population or 10 million people should be vaccinated by mid-2022.

According to Bloomberg, Indonesia was delighted with the effectiveness of the Chinese Sinovac vaccine with which it treated health workers in the capital Jakarta. According to the Indonesian Ministry of Health, more than 25,000 of the workers vaccinated with Sinovac showed promising signs within 28 days after vaccination. None of them had died and that from the 7 ^th day following vaccination, 97% of these had avoided hospitalization. The data, the agency continues, adds to positive signs from Brazil that the Sinovac vaccine is more effective than it has been proven during the testing phase.

Indonesia was one of the first countries to show confidence in the Chinese vaccine. In January, President Joko Widodo became the first great world leader to receive an injection of Sinovac in an attempt to quell skepticism at home and abroad. Since then, Southeast Asia’s largest economy has administered more than 22 million doses, mostly of Sinovac, as it seeks to achieve collective immunity for its 270 million people by the end of the year.

Cambodia has donated and/or purchased over 2 million total doses of Sinovac. According to the government’s agenda, 60% of the population or 10 million people should be vaccinated by mid-2022.